LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Bladder EpiCheck is the first urine biomarker methylation test of its kind to be FDA cleared for NMIBC surveillance (Photo courtesy of Nucleix)

First Of Its Kind Urine Biomarker Methylation Test Predicts Bladder Cancer Recurrence

A simple, objective urine test for recurrent bladder cancer that analyzes subtle disease-specific changes in DNA methylation markers, with high sensitivity and specificity, is set to become commercially available in the U.S. More...
09 May 2023
A study has found that ChemoID platform-predicted treatments led to longer survival (Photo courtesy of Freepik)

Cancer Stem Cell Test Improves Survival of Patients with Deadly Brain Tumor

A new study has found that a cancer stem cell test can accurately determine more effective treatments, resulting in increased survival rates for patients with glioblastoma, a lethal brain tumor. More...
09 May 2023
DIASOURCE (A Biovendor Company)
Image: PocDoc offers the world’s first app based five marker lipid test (Photo courtesy of PocDoc)

World-First Smartphone-Powered 5 Marker Lipid Test Aids in Early Detection of Cardiovascular Diseases

An innovative diagnostic tool for cardiovascular disease enables early detection by facilitating accurate blood testing via a smartphone or tablet, with results accessible through an app. More...
05 May 2023
Image: D3 Array enables rapid and accurate molecular testing (Photo courtesy of PathogenDx)

Microarray-Based Test to Help Better Understand and Detect Complicated UTI Infections

A single test can identify over 20 organisms and an extensive range of drug-resistant genes, facilitating the development of targeted treatment plans for Urinary Tract Infections (UTIs). More...
05 May 2023
Image: The single automated device can run hematology, clinical chemistry, and immunoassays subsystems in parallel (Photo courtesy of Freepik)

Single Automated Analyzer to Bring Full Suite of Diagnostics to Wherever Patients Are

A novel platform that delivers swift results using minimal blood volumes incorporates technology that facilitates automation and adaptable form factors outside centralized labs, bridging the gap between diagnostics and treatment. More...
04 May 2023
Image: The experimental setup to capture CTCs and CAFs (Photo courtesy of Scientific Reports)

Glass Filters to Separate Tumor Cells in Blood Tests Can Speed Up Cancer Diagnosis

Researchers have identified the optimal dimensions of glass filters for capturing circulating tumor cells (CTCs) and cancer-associated fibroblasts (CAFs) released by tumors into blood samples, demonstrating their ability to detect cells from lung cancer patients. More...
04 May 2023
Image: Cxbladder comprises a suite of tests, each optimized for a different point in the patient journey (Photo courtesy of Pacific Edge)

Genomic Urine Test Enables Non-Invasive Detection of Bladder and Other Urinary Tract Cancers

A set of non-invasive genomic urine tests can now efficiently and accurately detect or rule out bladder cancer by measuring five biomarker genes at the molecular level. More...
03 May 2023
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Integrated Biochemical & Immunological System
Biolumi CX8


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
PURITAN MEDICAL